David Barthel

David Barthel Email and Phone Number

CEO I Finance I Operations I Strategy I Uncovering unknown roadblocks and opportunities to profit and grow I Public, Private, Private Equity, M&A I Inciting innovation and excellence in Medical Device companies @ Marizyme Inc
David Barthel's Location
Whitehouse Station, New Jersey, United States, United States
David Barthel's Contact Details

David Barthel personal email

About David Barthel

I am a bold and authentic CEO with a refined ability to solicit strategic alliances, analyze solutions, and launch to achieve long-term sustainable success. My diversity of experience lends itself to broad impacts that build trust and permit influence catapulting change, revenue, cash flow, and growth. I’ve built my career at the nexus of Strategic Direction, Growth & Integration, and Banking & Lending, establishing, cleaning up and stabilizing businesses. As an innovative and adaptable leader, I influence start-ups, boutique firms, early stage, or large market leaders. I have a remarkable capacity to foster new relationships, utilize my vast business network, and infuse strong finance, infrastructure, and technology strategies and tactical road maps. My deep expertise in medical device start-up operations and the key drivers of that space have led me down multiple lucrative and revolutionary paths. Over my career, I’ve pioneered and directed innovation, accelerated sales, and transformed as a change catalyst. I’ve identified trends and opportunities and created strategy that ensured remarkable security and growth. I thrive at working across teams, building consensus that aligns diverse groups with a clear purpose and inspires unified action that pushes critical business objectives across the finish line. I often design quick wins to achieve momentum, propelling commitment to long-term efforts.I’m particularly adept at tackling large, multi-faceted finance and growth challenges, breaking them into solvable pieces, and devising iterative plans that solve problems. I have repeatedly sustained a North Star focus during multi-year enterprise initiatives in the face of budget impacts, economic disruption, leadership changes and challenges, reorganizations, and M&A.If there is one thing that sets me apart, it is my ability to uncover the unseen. Where leadership previously has been blind to the root causes of critical challenges, I lead in the discovery and then acceptance of what is needed most to turn around complex and intertwined situations. I see what others don’t, can’t, or won’t.At my core, I’m a builder. Designing and leading start-up, early-stage and large initiatives, I create best-in-class capabilities that increase revenue, efficiencies, and effectiveness while reducing costs and delivering true transformation and systemic change to support a growth agenda.

David Barthel's Current Company Details
Marizyme Inc

Marizyme Inc

View
CEO I Finance I Operations I Strategy I Uncovering unknown roadblocks and opportunities to profit and grow I Public, Private, Private Equity, M&A I Inciting innovation and excellence in Medical Device companies
David Barthel Work Experience Details
  • Marizyme Inc
    Chief Executive Officer
    Marizyme Inc Nov 2021 - Present
    Jupiter, Florida, Us
    .At Marizyme, my task is raising capital and aligning business priorities with limited resources in a publicly traded micro-cap medical device company needing FDA approval and a total business transformation. Early on I identified and partnered with an Investment Bank to raise capital and move through the Nasdaq uplisting process using my deep understanding of SEC regulations. I’ve focused on critical priorities and minimizing risk by building valuation drivers around a robust diversified product pipeline, CE-generated revenue, monetized data, a deep IP portfolio, and multiple channels . My persistent optimism has never been more evident than in partnering with investors, structuring the financing, fostering relationships, closing, and using the capital to increase shareholder value in an extremely difficult capital market. Nonetheless, I have transformed, advanced, and commercialized DuraGraft, an FDA-cleared and CE-marked storage and flushing solution for preventing vein graft failure during Coronary Bypass Graft Surgery. I ideated and executed visionary strategies, developing, and commercializing multiple platform technologies for cardiac surgery, fat grafting, and organ transplant. In addition, I raised capital leading to S-1 process completion and future up-listing to Nasdaq, driving current global revenue growth and establishing future commercial viability across multiple disciplines, strategic partners, and sales channels. Noteworthy, I’ve escalated shareholder value by aligning resources with revenue priorities, FDA clearance, manufacturing, US commercialization and clinical trials all while serving as a trusted advisor and SME to physicians, researchers, strategic partners, investment bankers and the Board. In future-forward action, I established a strategic clinical and utilization partnership for DuraGraft with HCA for 2025. As a final note, I doubled revenue growth with a targeted distribution plan and my vast network in Europe and Asia in one year.
  • Henry Schein
    Managing Director, Brasseler Medical, Orthopedic Surgical Instrumentation
    Henry Schein Jul 2019 - Feb 2021
    Melville, Ny, Us
    At Henry Schein, in the Brasseler Medical for the Orthopedic Surgical Medical Division, I directed international revenue, product management, and marketing across the globe. Most notably, I led the US market launch of the EZX Acetabular Cup removal system for hip revision surgery and established worldwide distribution partners, growing global revenue 8% in one year. I also developed and executed five new product launch plans in 2021, skyrocketing revenue $5M.
  • Medtronic Gih
    Area Vice President
    Medtronic Gih Oct 2012 - Jul 2019
    In this position, I led profitable growth with full P&L responsibility for the Southeast division of 77 managers with 11 product capital and disposable platforms for GI Health, a business unit of minimally invasive therapies group of $30B Medtronic PLC. I authored and executed aggressive business plans emphasizing 18% unit growth across 6 diagnostic and therapeutic product platforms and 5 capital product platforms. As a result, I finished FY 2018 at 101% total revenue to quota with 12% revenue growth over FY 2017. I also sourced and seated 17 new account managers in FY 2016 escalating revenue growth 10.5%. In the middle of my term, I led the division through a complete reorganization including new product platforms and top talented sales teams in 3 years. I also developed and directed a direct sales force, encompassing product platforms for Capsule Endoscopy, EUS, diagnosis for GERD and Reflux, and treatment of Barrett’s Esophagus and Liver Cancer. In more detail of my role, I also authored budgets, forecasts, and strategic finance plans, collaborating with Finance, Sales Operations, Organizational Development, Marketing, Reimbursement, Product Development, and the Commercial Leadership Team. I led double-digit growth with multi-product platforms for diagnostic and therapeutic GI Health and built a revenue growth foundation through a strategy of utilizing internal and external resources, clinical and business acumen, and a culture of teamwork, transparency, accountability, and overcommunication.
  • Given Imaging (Previously The Smartpill Corporation)
    Vice President, Smartpill
    Given Imaging (Previously The Smartpill Corporation) Oct 2012 - Oct 2014
    Before the acquisition of The SmartPill Corp. by Given, as President and CEO, I raised capital and built resources in line with a private start-up medical device company and single-handedly built the company without an initial product from start-up to concept through the sale of a revenue-generating business to Given. I catapulted from concept through design, prototypes, software development, clinical trials, FDA approvals (and CE approval in Europe), and CPT Code Reimbursement approval. I identified early-stage investors, including Venture Capitalists, Investment Banks, and Strategic Partners, structuring the finance for a positive ROI and closing on capital. As I founded the company, I recruited and hired Engineering, Sales, Marketing, and Quality, Regulatory, Operations and Reimbursement. executives. I developed a Quality Management System, Performance Management System, Design Control, and defined the clinical trial pathway to complete 3 multi-centered clinical trials. Remarkedly, I boosted revenue by 25% every year from product release forward and achieved $2.5M in revenue in 2012. I also raised $76M through multiple funding rounds (series A, B, C) from leading venture capital firms, including Psilos and Oxford Biosciences, sophisticated high-net-worth investors, and Kimberly Clark. I aligned limited resources with critical priorities and met early milestones to motivate and sustain momentum and raise additional capital. At Given, I expanded the profit and performance worldwide of the SmartPill product platform, led clinical trials and reimbursement, and managed the complete P&L in this Israeli-based technology company manufacturing and marketing diagnostic products disorders of the GI tract. One of my many achievements was developing the marketing strategy for global expansion, sales plans and channels, and use indications including for pediatrics. I launched new markets, opened and drove $2M of sales through the Pharma channel and grew revenue 10% in a year.

David Barthel Skills

Leadership Consultative Selling Sales Process Sales Force Development Strong Hands On Leadership Business Acumen Accountability Sales Operations Communication Team Leadership Medical Devices Raised $80m In Equity Financing Strategy Resource Allocation And Resources Cross Functional Team Leadership Ability To Lead And Build A Dynamic Team To Drive Revenue Growth Capital Equipment Teamwork Management Excellent Business And Finance Analytics Product Launch Market Development Strong Clinical Acumen In Gi

David Barthel Education Details

  • Lake Forest Graduate School Of Management
    Lake Forest Graduate School Of Management
    General
  • St. Norbert College
    St. Norbert College
    Bachler Of Arts

Frequently Asked Questions about David Barthel

What company does David Barthel work for?

David Barthel works for Marizyme Inc

What is David Barthel's role at the current company?

David Barthel's current role is CEO I Finance I Operations I Strategy I Uncovering unknown roadblocks and opportunities to profit and grow I Public, Private, Private Equity, M&A I Inciting innovation and excellence in Medical Device companies.

What is David Barthel's email address?

David Barthel's email address is da****@****ail.com

What schools did David Barthel attend?

David Barthel attended Lake Forest Graduate School Of Management, St. Norbert College.

What skills is David Barthel known for?

David Barthel has skills like Leadership, Consultative Selling, Sales Process, Sales Force Development, Strong Hands On Leadership, Business Acumen, Accountability, Sales Operations, Communication, Team Leadership, Medical Devices, Raised $80m In Equity Financing.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.